Kevin J. Croce
MD, PhD
​
Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.
Jon George
MD
​
Dr. Jon C. George, MD is a highly regarded Interventional Cardiologist recognized for his significant contributions to the advancement of complex coronary and peripheral vascular interventions. Over the course of his career, Dr. George has played a pivotal role in shaping contemporary interventional practice through clinical innovation, research, education, and early evaluation of novel cardiovascular devices. Dr. George has extensive experience in the treatment of complex coronary artery disease, including chronic total occlusions (CTOs), calcified lesions, and high-risk percutaneous coronary interventions. He has been at the forefront of adopting and refining advanced interventional techniques and has actively contributed to the development and clinical assessment of new catheter-based technologies aimed at improving procedural success and patient outcomes. A prolific academic contributor, Dr. George has authored over 100 peer-reviewed publications, numerous book chapters, and has served as editor of the Evidence-Based Guide to Interventional Cardiology and Endovascular Medicine. His research spans clinical trials, device innovation, imaging-guided interventions, and outcomes-based studies, reflecting a strong commitment to evidence-driven progress in the field. Dr. George has also been deeply involved in first-in-human and early-feasibility studies, working closely with industry and academic partners to translate emerging technologies from concept to clinical practice. His ability to bridge clinical need with device design has made him a trusted advisor in cardiovascular innovation.
Sanjog Kalra
MD, MSc, FSCAI | SCAI
Dr. Sanjog Kalra is a distinguished interventional cardiologist and cardiac critical care physician based at the Peter Munk Cardiac Centre, Toronto General Hospital, and an esteemed faculty member at the University of Toronto, Canada. Trained in Internal Medicine and Cardiology with specialized fellowship training in complex, high-risk coronary interventions (CHIP), Dr. Kalra is internationally recognized for his expertise in advanced percutaneous coronary techniques, chronic total occlusion (CTO) procedures, and mechanical circulatory support. His clinical and research work focuses on improving outcomes in complex cardiovascular disease, and he has led workshops and educational initiatives around the world to advance interventional practice. Dr. Kalra’s deep commitment to innovation and excellence in cardiovascular care makes him a valued advisor to the Lumivascular team
Mitul Patel
MD, FSCAI
Dr. Mitul Patel is a highly respected Interventional Cardiologist affiliated with Intermountain Medical Center in Salt Lake City, Utah, and a recognized expert in the percutaneous treatment of complex cardiovascular disease. Dr. Patel completed his fellowship training in Cardiovascular Disease and Interventional Cardiology at the University of California San Diego Health and is board-certified in interventional cardiology. He has extensive expertise in managing chronic total occlusions in both coronary and peripheral vascular beds, performing advanced procedures such as balloon pulmonary angioplasty and the use of percutaneous ventricular assist devices for complex interventions and cardiogenic shock. Dr. Patel’s clinical leadership and dedication to advancing interventional techniques make him a vital contributor to Lumivascular.
Rhian E Davies
DO,MS, FACC, FSCAI
Dr. Rhian E. Davies is an Interventional Cardiologist and Director of the Complex Coronary Program at WellSpan Health. She specializes in complex and high-risk percutaneous coronary interventions (CHIP), including the treatment of chronic total occlusions (CTOs) and advanced coronary artery disease. With advanced fellowship training from leading academic medical centres including Penn State Milton S. Hershey Medical Centre, Warren Alpert Medical School of Brown University, and University of Washington Medical Centre, Dr. Davies brings extensive expertise in image-guided interventions and complex coronary procedures. As a member of Lumivascular’s Clinical Advisory Board, Dr. Davies provides strategic clinical insight into the development and adoption of next-generation image-guided technologies for the treatment of chronic total occlusions and complex vascular disease, supporting innovation aimed at improving procedural precision and patient outcomes.